This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Advanced Cancer
and you are
between 18 and 70
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

To study the pharmacokinetic characteristics of TQ-B3101 in the human body, recommend a reasonable regimen for subsequent research.

Provided treatments

  • Drug: TQ-B3101

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03019276. The sponsor of the trial is Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and it is looking for 20 volunteers for the current phase.
Official trial title:
Phase I Study of Tolerance and Pharmacokinetics of TQ-B3101 in Patients With Advanced Cancer